Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
178,442Documents
1,450Full text
2026-09-30Last indexed
Recent documents from this source
- Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19#143660
- Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older#143659
- PREVENT Pilot HPV - Related Cancers Trial#143658
- Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine#143657
- A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants#143656
- Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults#143655
- A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules#143654
- Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs#143653
- Thimble Mindfulness App and Recovery Patch Descriptions#143652
- A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa#143651
- Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine#143650
- Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)#143649
- Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine#143648
- Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010#143647
- A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine#143646
- This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama#143645
- Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation#143644
- REAl LIfe" Observational Study on the Effectiveness of Evusheld Prophylaxis Against SARS-CoV-2 Omicron Variants in Vaccine Non-responder Immunocompromised Patients#143643
- Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2#143642
- Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children#143641
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).